SCHEMBL18178367

SCHEMBL18178367

COC(=O)Oc1cccc(C)c1COc1cc(C)c(C)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.41
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
PTPN1 P18031 1/20 0.39
CUL4A Q13619 1/20 0.38
SGMS2 Q8NHU3 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
CD274 Q9NZQ7 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178366 0.93 CUL4A (0.38) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18178153 0.91 SLC22A12 (0.39) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18156228 0.91 SLC22A12 (0.39) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18178267 0.91 SLC22A12 (0.39) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18178365 0.89 CUL4A (0.36) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18178372 0.89 CD274 (0.38) SLC22A12LMNAL3MBTL1MAPTRAB9A
SCHEMBL18178363 0.89 PTGER1 (0.40) L3MBTL1CUL4AKDM4EHPGDHSD17B10
SCHEMBL18178371 0.89 LMNA (0.39) LMNAL3MBTL1MAPTCUL4AKDM4E
SCHEMBL18178364 0.89 MRGPRX4 (0.38) RAB9ACUL4ASGMS2KDM4EHPGD
SCHEMBL18178379 0.88 SLC22A12 (0.47) SLC22A12LMNAL3MBTL1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 SLC22A12 4500/4885LMNA 4171/4885L3MBTL1 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.